Announcement • Jun 06
Lihit Lab.,Inc. to Report Q1, 2027 Results on Jul 03, 2026 Lihit Lab.,Inc. announced that they will report Q1, 2027 results on Jul 03, 2026 New Risk • Apr 15
New major risk - Dividend sustainability The dividend is not well covered by earnings and cash flows. Payout ratio: 127% The company is paying a dividend despite having no free cash flows. Dividend yield: 2.1% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 127% Paying a dividend despite having no free cash flows. Earnings have declined by 10% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (0.7% net profit margin). Market cap is less than US$100m (JP¥3.97b market cap, or US$25.0m). Reported Earnings • Apr 05
Full year 2026 earnings released: EPS: JP¥19.75 (vs JP¥121 in FY 2025) Full year 2026 results: EPS: JP¥19.75 (down from JP¥121 in FY 2025). Revenue: JP¥9.12b (down 1.0% from FY 2025). Net income: JP¥67.0m (down 84% from FY 2025). Profit margin: 0.7% (down from 4.5% in FY 2025). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Announcement • Apr 03
Lihit Lab.,Inc., Annual General Meeting, May 21, 2026 Lihit Lab.,Inc., Annual General Meeting, May 21, 2026. Announcement • Apr 02
Lihit Lab.,Inc. to Report Fiscal Year 2026 Results on Apr 03, 2026 Lihit Lab.,Inc. announced that they will report fiscal year 2026 results on Apr 03, 2026 Upcoming Dividend • Feb 19
Upcoming dividend of JP¥25.00 per share Eligible shareholders must have bought the stock before 26 February 2026. Payment date: 07 May 2026. Payout ratio is a comfortable 41% but the company is not cash flow positive. Trailing yield: 1.9%. Lower than top quartile of Japanese dividend payers (3.4%). In line with average of industry peers (2.0%). Reported Earnings • Jan 10
Third quarter 2026 earnings released: JP¥1.47 loss per share (vs JP¥55.11 profit in 3Q 2025) Third quarter 2026 results: JP¥1.47 loss per share (down from JP¥55.11 profit in 3Q 2025). Revenue: JP¥1.91b (down 7.9% from 3Q 2025). Net loss: JP¥5.00m (down 103% from profit in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Announcement • Nov 27
Lihit Lab.,Inc. to Report Q3, 2026 Results on Jan 09, 2026 Lihit Lab.,Inc. announced that they will report Q3, 2026 results on Jan 09, 2026 Reported Earnings • Oct 04
Second quarter 2026 earnings released: EPS: JP¥2.36 (vs JP¥4.72 loss in 2Q 2025) Second quarter 2026 results: EPS: JP¥2.36 (up from JP¥4.72 loss in 2Q 2025). Revenue: JP¥2.08b (flat on 2Q 2025). Net income: JP¥8.00m (up JP¥24.0m from 2Q 2025). Profit margin: 0.4% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Announcement • Aug 09
Lihit Lab.,Inc. to Report Q2, 2026 Results on Oct 03, 2025 Lihit Lab.,Inc. announced that they will report Q2, 2026 results on Oct 03, 2025 Reported Earnings • Jul 06
First quarter 2026 earnings released: EPS: JP¥7.37 (vs JP¥17.39 in 1Q 2025) First quarter 2026 results: EPS: JP¥7.37 (down from JP¥17.39 in 1Q 2025). Revenue: JP¥2.80b (up 4.0% from 1Q 2025). Net income: JP¥25.0m (down 58% from 1Q 2025). Profit margin: 0.9% (down from 2.2% in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Announcement • Jul 03
Lihit Lab.,Inc. to Report Q1, 2026 Results on Jul 04, 2025 Lihit Lab.,Inc. announced that they will report Q1, 2026 results on Jul 04, 2025 Reported Earnings • Apr 05
Full year 2025 earnings released: EPS: JP¥121 (vs JP¥27.41 loss in FY 2024) Full year 2025 results: EPS: JP¥121 (up from JP¥27.41 loss in FY 2024). Revenue: JP¥9.22b (up 4.7% from FY 2024). Net income: JP¥411.0m (up JP¥504.0m from FY 2024). Profit margin: 4.5% (up from net loss in FY 2024). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Announcement • Apr 04
Lihit Lab.,Inc., Annual General Meeting, May 22, 2025 Lihit Lab.,Inc., Annual General Meeting, May 22, 2025. Upcoming Dividend • Feb 20
Upcoming dividend of JP¥25.00 per share Eligible shareholders must have bought the stock before 27 February 2025. Payment date: 08 May 2025. Payout ratio is a comfortable 42% but the company is not cash flow positive. Trailing yield: 2.0%. Lower than top quartile of Japanese dividend payers (3.8%). In line with average of industry peers (2.1%). Announcement • Feb 07
Lihit Lab.,Inc. to Report Fiscal Year 2025 Results on Apr 04, 2025 Lihit Lab.,Inc. announced that they will report fiscal year 2025 results on Apr 04, 2025 Reported Earnings • Jan 08
Third quarter 2025 earnings released: EPS: JP¥55.11 (vs JP¥18.86 loss in 3Q 2024) Third quarter 2025 results: EPS: JP¥55.11 (up from JP¥18.86 loss in 3Q 2024). Revenue: JP¥2.07b (flat on 3Q 2024). Net income: JP¥187.0m (up JP¥251.0m from 3Q 2024). Profit margin: 9.0% (up from net loss in 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance. Announcement • Nov 16
Lihit Lab.,Inc. to Report Q3, 2025 Results on Jan 07, 2025 Lihit Lab.,Inc. announced that they will report Q3, 2025 results on Jan 07, 2025 Reported Earnings • Oct 09
Second quarter 2025 earnings released: JP¥4.72 loss per share (vs JP¥1.18 profit in 2Q 2024) Second quarter 2025 results: JP¥4.72 loss per share (down from JP¥1.18 profit in 2Q 2024). Revenue: JP¥2.08b (up 3.9% from 2Q 2024). Net loss: JP¥16.0m (down JP¥20.0m from profit in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 120 percentage points per year, which is a significant difference in performance. New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (JP¥3.77b market cap, or US$26.8m). Announcement • Sep 05
Lihit Lab.,Inc. to Report Q2, 2025 Results on Oct 04, 2024 Lihit Lab.,Inc. announced that they will report Q2, 2025 results on Oct 04, 2024 New Risk • Aug 05
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.8% average weekly change). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 49% per year over the past 5 years. Minor Risk Market cap is less than US$100m (JP¥3.39b market cap, or US$23.8m). Reported Earnings • Jul 08
First quarter 2025 earnings released: EPS: JP¥17.39 (vs JP¥2.06 loss in 1Q 2024) First quarter 2025 results: EPS: JP¥17.39 (up from JP¥2.06 loss in 1Q 2024). Revenue: JP¥2.69b (up 5.9% from 1Q 2024). Net income: JP¥59.0m (up JP¥66.0m from 1Q 2024). Profit margin: 2.2% (up from net loss in 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 123 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Jul 01
Now 18% undervalued Over the last 90 days, the stock has risen 26% to JP¥1,218. The fair value is estimated to be JP¥1,477, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Announcement • Jun 29
Lihit Lab.,Inc. to Report Q1, 2025 Results on Jul 05, 2024 Lihit Lab.,Inc. announced that they will report Q1, 2025 results on Jul 05, 2024 Buy Or Sell Opportunity • Jun 18
Now 20% undervalued Over the last 90 days, the stock has risen 21% to JP¥1,172. The fair value is estimated to be JP¥1,472, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Jun 04
Now 23% undervalued Over the last 90 days, the stock has risen 21% to JP¥1,150. The fair value is estimated to be JP¥1,502, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. New Risk • Jun 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 46% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Market cap is less than US$100m (JP¥4.19b market cap, or US$26.8m). Reported Earnings • Apr 07
Full year 2024 earnings released: JP¥27.41 loss per share (vs JP¥7.07 loss in FY 2023) Full year 2024 results: JP¥27.41 loss per share (further deteriorated from JP¥7.07 loss in FY 2023). Revenue: JP¥8.80b (up 3.4% from FY 2023). Net loss: JP¥93.0m (loss widened 288% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 108 percentage points per year, which is a significant difference in performance. Announcement • Apr 05
Lihit Lab.,Inc. to Report Fiscal Year 2024 Results on Apr 05, 2024 Lihit Lab.,Inc. announced that they will report fiscal year 2024 results on Apr 05, 2024 Upcoming Dividend • Feb 21
Upcoming dividend of JP¥25.00 per share Eligible shareholders must have bought the stock before 28 February 2024. Payment date: 09 May 2024. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.5%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.8%). Reported Earnings • Jan 10
Third quarter 2024 earnings released: JP¥18.86 loss per share (vs JP¥7.37 loss in 3Q 2023) Third quarter 2024 results: JP¥18.86 loss per share (further deteriorated from JP¥7.37 loss in 3Q 2023). Revenue: JP¥2.06b (up 1.7% from 3Q 2023). Net loss: JP¥64.0m (loss widened 156% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance. Announcement • Dec 27
Lihit Lab.,Inc. to Report Q3, 2024 Results on Jan 09, 2024 Lihit Lab.,Inc. announced that they will report Q3, 2024 results on Jan 09, 2024 Reported Earnings • Oct 07
Second quarter 2024 earnings released: EPS: JP¥1.18 (vs JP¥8.84 loss in 2Q 2023) Second quarter 2024 results: EPS: JP¥1.18 (up from JP¥8.84 loss in 2Q 2023). Revenue: JP¥2.00b (up 12% from 2Q 2023). Net income: JP¥4.00m (up JP¥34.0m from 2Q 2023). Profit margin: 0.2% (up from net loss in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance. Announcement • Aug 03
Lihit Lab.,Inc. to Report Q2, 2024 Results on Oct 06, 2023 Lihit Lab.,Inc. announced that they will report Q2, 2024 results on Oct 06, 2023 Reported Earnings • Jul 08
First quarter 2024 earnings released: JP¥2.06 loss per share (vs JP¥27.41 profit in 1Q 2023) First quarter 2024 results: JP¥2.06 loss per share (down from JP¥27.41 profit in 1Q 2023). Revenue: JP¥2.54b (flat on 1Q 2023). Net loss: JP¥7.00m (down 108% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Announcement • Jun 30
Lihit Lab.,Inc. to Report Q1, 2024 Results on Jul 07, 2023 Lihit Lab.,Inc. announced that they will report Q1, 2024 results on Jul 07, 2023 Reported Earnings • May 30
Full year 2023 earnings released: JP¥7.07 loss per share (vs JP¥77.22 profit in FY 2022) Full year 2023 results: JP¥7.07 loss per share (down from JP¥77.22 profit in FY 2022). Revenue: JP¥8.51b (down 2.1% from FY 2022). Net loss: JP¥24.0m (down 109% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Reported Earnings • Apr 08
Full year 2023 earnings released: JP¥7.07 loss per share (vs JP¥77.22 profit in FY 2022) Full year 2023 results: JP¥7.07 loss per share (down from JP¥77.22 profit in FY 2022). Revenue: JP¥8.51b (down 2.1% from FY 2022). Net loss: JP¥24.0m (down 109% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Upcoming Dividend • Feb 20
Upcoming dividend of JP¥25.00 per share at 2.8% yield Eligible shareholders must have bought the stock before 27 February 2023. Payment date: 09 May 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.2%). Announcement • Feb 17
Lihit Lab.,Inc. to Report Fiscal Year 2023 Results on Apr 07, 2023 Lihit Lab.,Inc. announced that they will report fiscal year 2023 results on Apr 07, 2023 Reported Earnings • Jan 08
Third quarter 2023 earnings released: JP¥7.37 loss per share (vs JP¥12.96 profit in 3Q 2022) Third quarter 2023 results: JP¥7.37 loss per share (down from JP¥12.96 profit in 3Q 2022). Revenue: JP¥2.02b (flat on 3Q 2022). Net loss: JP¥25.0m (down 157% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Announcement • Dec 04
Lihit Lab., Inc. to Report Q3, 2023 Results on Jan 06, 2023 Lihit Lab., Inc. announced that they will report Q3, 2023 results on Jan 06, 2023 Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 3 highly experienced directors. No independent directors (9 non-independent directors). President and Representative Director Hirokazu Tanaka was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Oct 09
Second quarter 2023 earnings released: JP¥8.84 loss per share (vs JP¥4.13 profit in 2Q 2022) Second quarter 2023 results: JP¥8.84 loss per share (down from JP¥4.13 profit in 2Q 2022). Revenue: JP¥1.79b (down 5.4% from 2Q 2022). Net loss: JP¥30.0m (down 314% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Announcement • Aug 19
Lihit Lab., Inc. to Report Q2, 2023 Results on Oct 07, 2022 Lihit Lab., Inc. announced that they will report Q2, 2023 results on Oct 07, 2022 Reported Earnings • Jul 10
First quarter 2023 earnings released: EPS: JP¥27.41 (vs JP¥54.25 in 1Q 2022) First quarter 2023 results: EPS: JP¥27.41 (down from JP¥54.25 in 1Q 2022). Revenue: JP¥2.53b (down 6.2% from 1Q 2022). Net income: JP¥93.0m (down 50% from 1Q 2022). Profit margin: 3.7% (down from 6.8% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Reported Earnings • Jun 02
Full year 2022 earnings released: EPS: JP¥77.21 (vs JP¥104 in FY 2021) Full year 2022 results: EPS: JP¥77.21 (down from JP¥104 in FY 2021). Revenue: JP¥8.69b (up 1.5% from FY 2021). Net income: JP¥262.0m (down 26% from FY 2021). Profit margin: 3.0% (down from 4.1% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 3 highly experienced directors. No independent directors (8 non-independent directors). President and Representative Director Hirokazu Tanaka was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Announcement • Apr 10
Lihit Lab., Inc., Annual General Meeting, May 26, 2022 Lihit Lab., Inc., Annual General Meeting, May 26, 2022. Reported Earnings • Apr 10
Full year 2022 earnings released: EPS: JP¥77.21 (vs JP¥104 in FY 2021) Full year 2022 results: EPS: JP¥77.21 (down from JP¥104 in FY 2021). Revenue: JP¥8.69b (up 1.5% from FY 2021). Net income: JP¥262.0m (down 26% from FY 2021). Profit margin: 3.0% (down from 4.1% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 7% per year. Announcement • Apr 08
Lihit Lab., Inc. to Report Fiscal Year 2022 Results on Apr 08, 2022 Lihit Lab., Inc. announced that they will report fiscal year 2022 results on Apr 08, 2022 Upcoming Dividend • Feb 18
Upcoming dividend of JP¥25.00 per share Eligible shareholders must have bought the stock before 25 February 2022. Payment date: 10 May 2022. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (2.1%). Reported Earnings • Jan 09
Third quarter 2022 earnings: Revenues in line with analyst expectations Third quarter 2022 results: Revenue: JP¥2.03b (up 1.0% from 3Q 2021). Net income: JP¥44.0m (down 51% from 3Q 2021). Profit margin: 2.2% (down from 4.4% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 6% per year. Valuation Update With 7 Day Price Move • Oct 19
Investor sentiment improved over the past week After last week's 24% share price gain to JP¥2,102, the stock trades at a trailing P/E ratio of 9.5x. Average trailing P/E is 16x in the Commercial Services industry in Japan. Total returns to shareholders of 10% over the past three years. Reported Earnings • Oct 09
Second quarter 2022 earnings released: EPS JP¥8.25 (vs JP¥13.56 in 2Q 2021) The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥1.90b (down 1.3% from 2Q 2021). Net income: JP¥14.0m (down 39% from 2Q 2021). Profit margin: 0.7% (down from 1.2% in 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 4% per year. Reported Earnings • Jul 11
First quarter 2022 earnings released: EPS JP¥108 (vs JP¥88.44 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥2.70b (up 9.5% from 1Q 2021). Net income: JP¥184.0m (up 23% from 1Q 2021). Profit margin: 6.8% (up from 6.1% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 4% per year. Reported Earnings • Jun 02
Full year 2021 earnings released: EPS JP¥207 (vs JP¥199 in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: JP¥8.56b (down 13% from FY 2020). Net income: JP¥352.0m (up 4.5% from FY 2020). Profit margin: 4.1% (up from 3.4% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 6% per year. Reported Earnings • Apr 11
Full year 2021 earnings released: EPS JP¥207 (vs JP¥199 in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: JP¥8.56b (down 13% from FY 2020). Net income: JP¥352.0m (up 4.5% from FY 2020). Profit margin: 4.1% (up from 3.4% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 9% per year, which means it is performing significantly worse than earnings. Reported Earnings • Jan 09
Third quarter 2021 earnings released: EPS JP¥52.40 The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: JP¥2.01b (down 14% from 3Q 2020). Net income: JP¥89.0m (up 20% from 3Q 2020). Profit margin: 4.4% (up from 3.2% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Jan 07
New 90-day high: JP¥1,751 The company is up 4.0% from its price of JP¥1,683 on 09 October 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Commercial Services industry, which is flat over the same period. Announcement • Aug 15
Lihit Lab., Inc. to Report Q2, 2021 Results on Oct 09, 2020 Lihit Lab., Inc. announced that they will report Q2, 2021 results on Oct 09, 2020